{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:32:05Z","timestamp":1776274325827,"version":"3.50.1"},"reference-count":25,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.1080\/14740338.2021.1962846","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T16:12:48Z","timestamp":1627661568000},"page":"1559-1564","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":25,"title":["Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data"],"prefix":"10.1080","volume":"20","author":[{"given":"Anika","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9609-0199","authenticated-orcid":false,"given":"Ashwin","family":"Kamath","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00162-20"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.013679"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2023184"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007016"},{"key":"cit0007","unstructured":"Summary on compassionate use. Remdesivir Gilead. European Medicines. 2020. [cited 2021 Jun 19].\u00a0Available from: https:\/\/www.ema.europa.eu\/en\/documents\/other\/summary-compassionate-use-remdesivir-gilead_en.pdf"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106272"},{"key":"cit0009","unstructured":"Clinical guidance for management of adult COVID 19 patients. AIIMS\/ ICMR-COVID-19 national task force\/ joint monitoring group. Ministry of Health & Family Welfare, Government of India. 2021. [cited 2021 Jun 19]. Available from: https:\/\/www.icmr.gov.in\/pdf\/covid\/techdoc\/COVID_Management_Algorithm_17052021.pdf"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.18535\/ijmsci\/v8i01.03"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1856655"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.02.015"},{"key":"cit0013","unstructured":"VEKLURY\u00ae (remdesivir). United States food and drug administration. [cited 2021 Jun 22]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/214787Orig1s000lbl.pdf"},{"key":"cit0014","unstructured":"Questions and Answers on FDA\u2019s Adverse Event Reporting System (FAERS). United States food and drug administration. [cited 2021 Jun 19]. Available from: https:\/\/www.fda.gov\/drugs\/surveillance\/questions-and-answers-fdas-adverse-event-reporting-system-faers"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04037.x"},{"key":"cit0016","unstructured":"Screening for adverse reactions in EudraVigilance. European medicines agency. 2016. [cited 2021 Jun 22]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/other\/screening-adverse-reactions-eudravigilance_en.pdf"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2019.01.006"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2020.00019"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000706156.26271.8a"},{"key":"cit0020","doi-asserted-by":"crossref","first-page":"ciaa1851","DOI":"10.1093\/cid\/ciaa1851","author":"Pettit NN","year":"2020","journal-title":"Clin Infect Dis"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.12.003"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.02.013"},{"key":"cit0023","unstructured":"Meeting highlights from the pharmacovigilance risk. Assessment Committee (PRAC) 2021 Feb 8-11. European Medicines Agency. 2021. [cited 2021 Jun 23]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-february-2021"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5371"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015301"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2021.1962846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T13:46:32Z","timestamp":1637588792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2021.1962846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,2]]}},"alternative-id":["10.1080\/14740338.2021.1962846"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2021.1962846","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}